| Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre … R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ... The lancet oncology 15 (10), 1100-1108, 2014 | 1070 | 2014 |
| Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of … LB Nabors, KL Fink, T Mikkelsen, D Grujicic, R Tarnawski, DH Nam, ... Neuro-oncology 17 (5), 708-717, 2015 | 233 | 2015 |
| Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer–report on 3-year tumour control and normal tissue toxicity K Skladowski, B Maciejewski, M Golen, B Pilecki, W Przeorek, ... Radiotherapy and Oncology 55 (2), 101-110, 2000 | 224 | 2000 |
| Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients R Suwinski, A Sowa, T Rutkowski, J Wydmanski, R Tarnawski, ... International Journal of Radiation Oncology* Biology* Physics 56 (2), 399-412, 2003 | 203 | 2003 |
| Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: an international multicenter phase II clinical trial … LK Mell, I Sirák, L Wei, R Tarnawski, U Mahantshetty, CM Yashar, ... International Journal of Radiation Oncology* Biology* Physics 97 (3), 536-545, 2017 | 155 | 2017 |
| 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas R Tarnawski, M Sokol, P Pieniazek, B Maciejewski, J Walecki, L Miszczyk, ... International Journal of Radiation Oncology* Biology* Physics 52 (5), 1271-1276, 2002 | 150 | 2002 |
| How fast is repopulation of tumor cells during the treatment gap? R Tarnawski, J Fowler, K Skladowski, A Świerniak, R Suwiński, ... International Journal of Radiation Oncology* Biology* Physics 54 (1), 229-236, 2002 | 145 | 2002 |
| Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx R Tarnawski, K Skladowski, B Maciejewski International Journal of Radiation Oncology* Biology* Physics 38 (5), 1007-1011, 1997 | 118 | 1997 |
| DALSA: Domain adaptation for supervised learning from sparsely annotated MR images M Goetz, C Weber, F Binczyk, J Polanska, R Tarnawski, ... IEEE transactions on medical imaging 35 (1), 184-196, 2015 | 100 | 2015 |
| Clinical radiobiology of glottic T1 squamous cell carcinoma K Skladowski, R Tarnawski, B Maciejewski, A Wygoda, K Slosarek International Journal of Radiation Oncology* Biology* Physics 43 (1), 101-106, 1999 | 96 | 1999 |
| European Organisation for Research and Treatment of Cancer (EORTC); Canadian Brain Tumor Consortium; CENTRIC study team. Cilengitide combined with standard treatment for … R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ... Lancet Oncol 15 (10), 1100-1108, 2014 | 89 | 2014 |
| Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial K Skladowski, B Maciejewski, M Golen, R Tarnawski, K Slosarek, ... International Journal of Radiation Oncology* Biology* Physics 66 (3), 706-713, 2006 | 87 | 2006 |
| Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer M Pietrowska, L Marczak, J Polanska, K Behrendt, E Nowicka, ... Journal of Translational Medicine 7, 1-13, 2009 | 84 | 2009 |
| Clinical radiobiology of stage T2-T3 bladder cancer W Majewski, B Maciejewski, S Majewski, R Suwinski, L Miszczyk, ... International Journal of Radiation Oncology* Biology* Physics 60 (1), 60-70, 2004 | 74 | 2004 |
| Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy R Suwinski, I Wzietek, R Tarnawski, A Namysl-Kaletka, M Kryj, ... International Journal of Radiation Oncology* Biology* Physics 69 (3), 793-799, 2007 | 62 | 2007 |
| Role of short TE 1H-MR spectroscopy in monitoring of post-operation irradiated patients J Walecki, M Sokól, P Pieniążek, B Maciejewski, R Tarnawski, T Krupska, ... European journal of radiology 30 (2), 154-161, 1999 | 60 | 1999 |
| Global challenges of radiotherapy for the treatment of locally advanced cervical cancer JS Mayadev, G Ke, U Mahantshetty, MD Pereira, R Tarnawski, T Toita International Journal of Gynecologic Cancer 32 (3), 2022 | 51 | 2022 |
| Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: can biopsy be obviated? RZ Slapa, W Jakubowski, A Januszewicz, AA Kasperlik-Zaluska, ... European Radiology 10, 95-104, 2000 | 51 | 2000 |
| 1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors T Rutkowski, R Tarnawski, M Sokol, B Maciejewski International Journal of Radiation Oncology* Biology* Physics 56 (5), 1381-1389, 2003 | 50 | 2003 |
| Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001 C Marth, R Tarnawski, A Tyulyandina, S Pignata, L Gilbert, D Kaen, ... International Journal of Gynecologic Cancer 32 (1), 2022 | 45 | 2022 |
